Chiu CC |
------>authors3_c=None ------>paper_class1=1 ------>Impact_Factor=4.419 ------>paper_class3=2 ------>paper_class2=4 ------>vol=25 ------>confirm_bywho=b521073 ------>insert_bywho=mongliang ------>Jurnal_Rank=8.9 ------>authors4_c=None ------>comm_author=1 ------>patent_EDate=None ------>authors5_c=None ------>publish_day=None ------>paper_class2Letter=None ------>page2=627 ------>medlineContent= ------>unit=E0120 ------>insert_date=20051202 ------>iam=2 ------>update_date=None ------>author=??? ------>change_event=4 ------>ISSN=None ------>authors_c=None ------>score=-10000 ------>journal_name=Journal of Clinical Psychopharmacology ------>paper_name=Comments on Articles by Albers et al: "Low-Dose Fluvoxamine as an Adjunct to Reduce Olanzapine Therapeutic Dose Requirements: A Prospective Dose-Adjusted Drug Interaction Strategy." ------>confirm_date=20060203 ------>tch_id=090001 ------>pmid=no found ------>page1=626 ------>fullAbstract=no found ------>tmu_sno=None ------>sno=11928 ------>authors2=Lu ML ------>authors3= ------>authors4= ------>authors5= ------>authors6= ------>authors6_c=None ------>authors=Chiu CC ------>delete_flag=0 ------>SCI_JNo=None ------>authors2_c=None ------>publish_area=None ------>updateTitle=no found ------>language=2 ------>check_flag=None ------>submit_date=None ------>country=None ------>no=6 ------>patent_SDate=None ------>update_bywho=None ------>publish_year=2005 ------>submit_flag=None ------>publish_month=None |